SCHEMBL30209101

SCHEMBL30209101

C[C@H](N)c1nc(-c2cccc(Cl)c2)cs1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 2/20 0.53
ATP4B P51164 2/20 0.53
CYP19A1 P11511 1/20 0.52
ABL1 P00519 1/20 0.51
MAPT P10636 4/20 0.49
RAB9A P51151 3/20 0.49
NPC1 O15118 1/20 0.49
GAA P10253 1/20 0.49
MAPK1 P28482 1/20 0.49
CFTR P13569 2/20 0.46
KDM1A O60341 1/20 0.46
MAOA P21397 1/20 0.46
GLA P06280 1/20 0.45
GSTO1 P78417 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
TSHR P16473 1/20 0.43
RECQL P46063 1/20 0.43
CYP1A1 P04798 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP1B1 Q16678 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2609413 0.88 CYP19A1 (0.55) ATP4AATP4BCYP19A1ABL1MAPT
SCHEMBL4583617 0.81 ALDH1A1 (0.56) ATP4AATP4BMAPTRAB9ANPC1
Hydrochloric Acid SCHEMBL7504446 0.80 ALDH1A1 (0.55) ATP4AATP4BMAPTRAB9ANPC1
SCHEMBL1804064 0.78 MAPT (0.65) ATP4AATP4BCYP19A1ABL1MAPT
SCHEMBL982911 0.76 RECQL (0.66) ATP4AATP4BCYP19A1ABL1MAPT
SCHEMBL9955024 0.76 CYP19A1 (0.67) ATP4AATP4BCYP19A1ABL1MAPT
SCHEMBL3765806 0.74 CYP19A1 (0.60) ATP4AATP4BCYP19A1ABL1MAPT
SCHEMBL6176532 0.73 CYP19A1 (0.59) ATP4AATP4BCYP19A1ABL1MAPT
SCHEMBL12293307 0.73 CYP19A1 (0.55) ATP4AATP4BCYP19A1ABL1MAPT
SCHEMBL8362185 0.73 ATP4A (0.59) ATP4AATP4BCYP19A1ABL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023001061-A1 CDK7 SELECTIVE INHIBITORS AS ANTICANCER AGENTS JINGRUI BIOPHARMA CO., LTD. (CN) 2023-01-26 WO disclosed